Those who quit during this period miss out on the dramatic improvements that follow
A few things make BPC-157 a frequent focus in the literature
Research published in Diabetes, Obesity and Metabolism found that people lost 17.3 percent of their body weight when they used a GLP-1 agonist
Lau J, Bloch P, Schaffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, et al
Stop Before You Are Full: Because GLP-1 medications delay the full signal, it is easy to overeat
Healthcare providers exercise independent medical judgment to determine whether GLP-1 therapy is medically appropriate for each individual based on their unique medical history, current health status, contraindications, medication interactions, lifestyle factors, and other relevant considerations